Current Status of Patient-Derived Ovarian Cancer Models
Ovarian cancer (OC) is one of the leading causes of female cancer death. Recent studies have documented its extensive variations as a disease entity, in terms of cell or tissue of origin, pre-cancerous lesions, common mutations, and therapeutic responses, leading to the notion that OC is a generic t...
Main Authors: | Yoshiaki Maru, Yoshitaka Hippo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/5/505 |
Similar Items
-
A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries
by: Danilo Fiore, et al.
Published: (2020-06-01) -
Current Status and Perspectives of Patient-Derived Models for Ewing’s Sarcoma
by: Tadashi Kondo
Published: (2020-09-01) -
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
by: Takeshi Namekawa, et al.
Published: (2019-01-01) -
Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma
by: Lucie Thorel, et al.
Published: (2023-10-01) -
Kinase Inhibitors in the Treatment of Ovarian Cancer: Current State and Future Promises
by: Aikaterini Skorda, et al.
Published: (2022-12-01)